Company news
Verici DX PLC news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Positive results for Clarava from validation study
September 6, 2022
Result of AGM and voting results
June 27, 2022
Distribution of Verici Dx shares by EKF
June 20, 2022
CEO Video Interview
June 15, 2022
Further data from TutevaT validation study
June 14, 2022
Commercial Team Appointments
June 9, 2022
Posting of Annual Report & Accounts
May 25, 2022
Results of TutevaT clinical validation study
May 12, 2022
Clinical Validation Study Update
April 1, 2022
Close of Subscription and Fundraise Update
March 11, 2022
Result of Fundraise
March 4, 2022
Proposed Fundraise
March 4, 2022
Successful completion of analytical validation
February 15, 2022
Progress and strategy update
January 12, 2022
ClaravaT and TutevaT complete testing requirements
January 6, 2022
Collaboration with Illumina
January 5, 2022
Grant of two CPT Codes by AMA
January 4, 2022
Launch of Barbara T. Murphy Endowed Lectureship
November 8, 2021
Launch of Career Development Research Grant
November 1, 2021
Lorenzo Gallon, MD, Appointed as Chair of S.A.B
September 13, 2021
Patient enrolment completed
August 31, 2021
Appointment of Non-executive Director
August 19, 2021
Acceptance to CLIA Program
July 27, 2021
First European Clinical Trial Site Initiated
July 20, 2021
Directorate Change
July 1, 2021
Non-executive Director receives award
June 24, 2021
Notice of Change of AGM Venue
May 5, 2021
Lease signed for laboratory
April 29, 2021
MTA secured to assess CTOT-19 samples
April 14, 2021
First clinical trial sites initiated in US
March 2, 2021
Capital Markets Day for Kidney Health
February 9, 2021
Accelerated CLIA approval strategy
February 8, 2021
Additional patent licence with Mount Sinai
January 11, 2021
Appointment of Senior Director
December 23, 2020
AIM Admission & First Day of Dealings
November 3, 2020
Calls
The 5 newest of 13 calls. Every call is listed under its year.
- Verici DX (LSE:VRCI) — Investor Update
Oct 27, 2026
Transcript - Verici DX (LSE:VRCI) — Investor Presentation
Jul 8, 2026
Transcript - Verici DX (LSE:VRCI) — Interim Results
Oct 7, 2025
Transcript - Verici DX (LSE:VRCI) — Business Update
Jul 16, 2024
Transcript - Verici DX (LSE:VRCI) Q2 2024 Earnings Call
Jul 15, 2024
Transcript
Decks
The 5 newest of 8 decks. Every deck is listed under its year.
- H1 2024 Earnings Presentation
Earnings · 19 slides · Jul 15, 2024
- H1 2023 Earnings Presentation
Earnings · 16 slides · October 2023
- Q4 2022 Earnings Presentation
Earnings · 25 slides · Jul 11, 2023
- H1 2022 Earnings Presentation
Earnings · 18 slides · September 2022
- FY2021 Earnings Presentation
Earnings · 10 slides · May 2022